A stool-based lens on one Lachnospiraceae fiber fermenter
A gut microbiome test analyzes DNA or RNA from a small stool sample to identify which microorganisms are present and in what proportions. Modern sequencing methods—such as 16S rRNA gene profiling or whole-metagenome sequencing—map out the community of bacteria and other microbes that live in your digestive tract, including genera within the Lachnospiraceae family. Some labs also use targeted assays to quantify specific organisms like Mediterraneibacter faecis. Because these data capture a living ecosystem, results reflect your current state rather than a permanent trait.
. Many members of its broader family, Lachnospiraceae, are known for fermenting dietary fiber into short-chain fatty acids (SCFAs), molecules tied to gut barrier health and immune signaling, though capabilities vary by species and strain.
Why a sentinel species earns its own readout
Your gut microbes help break down complex carbohydrates, harvest energy, produce signaling molecules, and train your immune system. When we measure specific players—like Mediterraneibacter faecis—we’re looking for patterns that hint at how well fiber fermentation and microbial cross-feeding are working. Lower-than-expected levels can appear with low-fiber eating, after antibiotics, or during periods of high stress and disrupted routines. Higher-than-expected levels can occur in the opposite context or as part of a broader shift in the community. Neither is a diagnosis on its own; it’s a clue about function and balance.
Big picture, your microbiome links to digestion, inflammation tone, and metabolic flexibility. Tracking a sentinel organism such as M. faecis alongside overall diversity can show how changes in your habits—like consistently eating a variety of plant fibers or improving sleep regularity—translate into microbial stability. Think of it like strength training: one workout doesn’t build muscle, but a pattern over weeks does. Regular microbiome testing focuses on patterns, not perfection, to support preventive care and long-term wellness.
How to read a relative-abundance value
Your report typically shows relative abundance: the percentage of Mediterraneibacter faecis compared to all microbes detected, often benchmarked against a reference population. In a balanced microbiome, M. faecis often appears as a modest slice of a diverse community. Diversity itself tends to correlate with resilience—more species can share the workload of fiber fermentation and cross-feeding. Some reports also summarize functional pathways (for example, genes involved in SCFA production), which provide context for how the community may be working.
When your result sits within an “expected” range for a healthy reference group, that usually signals efficient fiber handling, steady SCFA production by the community, and a calmer inflammatory baseline. Optimal ranges vary widely by person due to diet, geography, and even seasonal patterns, so a single number is less meaningful than the story over time. If your level is lower or higher than peers, it highlights an area to explore with your clinician—often starting with diet quality and consistency—because fiber types and overall eating patterns shape this organism’s niche.
Imbalanced or “dysbiotic” patterns may include reduced diversity, a tilt toward inflammation-associated species, or a relative loss of fiber-adapted organisms like many Lachnospiraceae. A low M. faecis on its own does not prove disease; it suggests a functional gap in fiber fermentation that could contribute to gas, irregularity, or bloating if the rest of the community doesn’t compensate. Conversely, a high relative abundance might reflect a narrow diet where a few organisms dominate. These findings are prompts for thoughtful investigation rather than standalone diagnoses.
Factors that move the signal quickly
Preanalytical factors also influence results: recent antibiotics, colonoscopy prep, acute GI illness, or probiotics can temporarily skew measurements. Because the microbiome fluctuates naturally, repeat testing and trendlines—ideally alongside inflammation or metabolic biomarkers—provide the clearest insight into how your gut ecosystem supports digestion, energy, and long-term health.
FAQs
The Mediterraneibacter faecis test analyzes the genetic material of bacteria, fungi, and other microorganisms in a stool sample to identify species diversity, relative abundance, and the community’s functional potential (what metabolic pathways or gene functions the microbiome may carry).
Results describe microbial balance and composition—which organisms are present and in what proportions and what functions they may perform—but do not by themselves diagnose or confirm the presence of a specific disease; clinical correlation is required for medical conclusions.
The mediterraneibacter faecis test is a simple at‑home stool collection performed using the small swab or sterile vial provided in your kit; you collect a small sample from a fresh stool according to the kit directions, seal the swab or vial, and prepare it for return shipping.
Maintain cleanliness to avoid contamination (wash hands before and after collection), clearly label the sample with the required information (name, date, and any kit ID), and follow the kit’s instructions for storage and shipment exactly — careful adherence is essential for accurate sequencing results.
Mediterraneibacter faecis test results can provide clues about how your gut is functioning: they may reflect aspects of digestion (such as capacity to break down fibers and other substrates, which can influence gas production and stool consistency), intestinal inflammation (microbial shifts that are associated with immune activation), nutrient absorption and production (including effects on vitamins and short‑chain fatty acids), metabolic processes (influences on energy extraction and pathways related to glucose and lipid handling), and gut–brain communication (microbial metabolites that can modulate mood, cognition and enteric nervous system signaling).
Keep in mind that microbiome patterns can correlate with, but don’t diagnose, specific health conditions—test results are one piece of the puzzle and should be interpreted alongside symptoms, clinical exams and laboratory tests by a qualified healthcare professional.
Next-generation sequencing provides high-resolution microbial data and can sensitively detect and quantify Mediterraneibacter faecis sequences, but interpretation of Mediterraneibacter faecis test results is probabilistic — sequencing reads, bioinformatic classification, assay sensitivity, and reference databases all contribute uncertainty rather than a binary yes/no answer.
Results represent a snapshot in time and may change with recent diet, stress, illness, or antibiotic use, so single-test findings can vary; for reliable interpretation consider trends or repeat testing and combine results with clinical context.
Many people test their mediterraneibacter faecis once per year to establish a baseline, or more frequently—every 3–6 months—when actively adjusting diet, probiotics, or other interventions.
Comparing results over time is more valuable than relying on a single reading: track consistent tests to observe trends and responses to changes rather than treating one-off values as definitive.
Yes — microbial populations, including mediterraneibacter faecis, can shift quickly: noticeable changes may occur within days after major dietary shifts, antibiotic use, illness, or other lifestyle changes, but more stable community patterns usually emerge over weeks to months as the gut ecosystem re-equilibrates.
For meaningful comparisons, maintain consistent diet and lifestyle for several weeks before retesting, since short-term fluctuations are common and can obscure longer-term trends.
References
- Togo, A. H., Diop, A., Bittar, F., Maraninchi, M., Valero, R., Armstrong, N., Dubourg, G., Labas, N., Richez, M., Delerce, J., Levasseur, A., Fournier, P. E., Raoult, D., & Million, M. (2018). Description of Mediterraneibacter massiliensis, gen. nov., sp. nov., a new genus isolated from the gut microbiota of an obese patient and reclassification of Ruminococcus faecis, Ruminococcus lactaris, Ruminococcus torques, Ruminococcus gnavus and Clostridium glycyrrhizinilyticum as Mediterraneibacter faecis comb. nov., Mediterraneibacter lactaris comb. nov., Mediterraneibacter torques comb. nov., Mediterraneibacter gnavus comb. nov. and Mediterraneibacter glycyrrhizinilyticus comb. nov. Antonie van Leeuwenhoek, 111(11), 2107-2128. https://doi.org/10.1007/s10482-018-1104-y
- Vacca, M., Celano, G., Calabrese, F. M., Portincasa, P., Gobbetti, M., & De Angelis, M. (2020). The controversial role of human gut Lachnospiraceae. Microorganisms, 8(4), 573. https://doi.org/10.3390/microorganisms8040573
- Fusco, W., Lorenzo, M. B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., Lener, E., Mele, M. C., Gasbarrini, A., Collado, M. C., Cammarota, G., & Ianiro, G. (2023). Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota. Nutrients, 15(9), 2211. https://doi.org/10.3390/nu15092211
- Jovel, J., Patterson, J., Wang, W., Hotte, N., O'Keefe, S., Mitchel, T., Perry, T., Kao, D., Mason, A. L., Madsen, K. L., & Wong, G. K.-S. (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. Frontiers in Microbiology, 7, 459. https://doi.org/10.3389/fmicb.2016.00459
- Drago, L. (2025). Navigating microbiome variability: Implications for research, diagnostics, and direct-to-consumer testing. Frontiers in Microbiology, 16, 1580531. https://doi.org/10.3389/fmicb.2025.1580531






































.avif)

